Clinical Trial Update: Metabolic Effects of Angiotensin-(1-7) [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating the metabolic effects of Angiotensin-(1-7) is currently recruiting in individuals with obesity and insulin resistance.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Insulin Resistance
• Metabolic Syndrome
• Obesity

Drugs mentioned

• Angiotensin-(1-7) (Angiotensin-(1-7))

Snippet

Sponsor: Vanderbilt University | Conditions: Obesity, Insulin Resistance | Phase 1 | Status: RECRUITING